Latham & Watkins LLP represented Zentalis Pharmaceuticals in the offering.Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting fundamental…
Zentalis Pharmaceuticals’ $150.4 Million Common Stock Offering
![](https://globallegalchronicle.com/wp-content/uploads/2021/07/zentalis-pharmaceuticals-150-4-million-common-stock-offering_60ee35d8c0782.jpeg)